Annual Total Assets
$19.19 M
-$648.00 K-3.27%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual total assets is $19.19 million, with the most recent change of -$648.00 thousand (-3.27%) on December 31, 2023.
- During the last 3 years, MACK annual total assets has risen by +$2.41 million (+14.38%).
Performance
MACK Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Assets
$244.32 M
+$225.13 M+1173.31%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly total assets is $244.32 million, with the most recent change of +$225.13 million (+1173.31%) on March 1, 2024.
- Over the past year, MACK quarterly total assets has increased by +$225.02 million (+1165.98%).
Performance
MACK Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
MACK Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -3.3% | +1166.0% |
3 y3 years | +14.4% | +1166.0% |
5 y5 years | -78.3% | +1166.0% |
MACK Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.3% | -23.1% | at high | -94.4% |
5 y | 5-year | -4.5% | -23.1% | at high | -94.4% |
alltime | all time | -91.8% | -23.1% | at high | -94.4% |
Merrimack Pharmaceuticals Total Assets History
Date | Annual | Quarterly |
---|---|---|
Mar 2024 | - | $244.32 M(+1173.3%) |
Dec 2023 | $19.19 M(-3.3%) | $19.19 M(-0.6%) |
Sep 2023 | - | $19.30 M(-0.8%) |
Jun 2023 | - | $19.45 M(-1.0%) |
Mar 2023 | - | $19.64 M(-1.0%) |
Dec 2022 | $19.84 M(+34.5%) | $19.84 M(+45.5%) |
Sep 2022 | - | $13.64 M(-3.0%) |
Jun 2022 | - | $14.05 M(-4.0%) |
Mar 2022 | - | $14.64 M(-0.7%) |
Dec 2021 | $14.75 M(-12.1%) | $14.75 M(-3.6%) |
Sep 2021 | - | $15.30 M(-3.5%) |
Jun 2021 | - | $15.86 M(-3.5%) |
Mar 2021 | - | $16.44 M(-2.0%) |
Dec 2020 | $16.78 M(-16.5%) | $16.78 M(-11.5%) |
Sep 2020 | - | $18.96 M(-3.7%) |
Jun 2020 | - | $19.68 M(-7.8%) |
Mar 2020 | - | $21.34 M(+6.3%) |
Dec 2019 | $20.08 M(-77.3%) | $20.08 M(-19.2%) |
Sep 2019 | - | $24.84 M(-44.8%) |
Jun 2019 | - | $45.04 M(-39.4%) |
Mar 2019 | - | $74.35 M(-16.0%) |
Dec 2018 | $88.54 M(-24.5%) | $88.54 M(-14.8%) |
Sep 2018 | - | $103.92 M(+29.5%) |
Jun 2018 | - | $80.23 M(-17.7%) |
Mar 2018 | - | $97.50 M(-16.9%) |
Dec 2017 | $117.33 M | $117.33 M(-40.7%) |
Sep 2017 | - | $197.85 M(-7.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2017 | - | $213.45 M(+211.0%) |
Mar 2017 | - | $68.64 M(-15.8%) |
Dec 2016 | $81.48 M(-65.3%) | $81.48 M(-31.2%) |
Sep 2016 | - | $118.41 M(-21.1%) |
Jun 2016 | - | $150.02 M(-22.2%) |
Mar 2016 | - | $192.93 M(-17.9%) |
Dec 2015 | $234.88 M(+48.2%) | $234.88 M(+128.7%) |
Sep 2015 | - | $102.68 M(-2.2%) |
Jun 2015 | - | $105.04 M(-17.3%) |
Mar 2015 | - | $127.02 M(-19.9%) |
Dec 2014 | $158.51 M(-17.6%) | $158.51 M(-16.0%) |
Sep 2014 | - | $188.60 M(+45.3%) |
Jun 2014 | - | $129.81 M(-21.3%) |
Mar 2014 | - | $164.98 M(-14.3%) |
Dec 2013 | $192.42 M(+29.2%) | $192.42 M(-14.2%) |
Sep 2013 | - | $224.24 M(+108.9%) |
Jun 2013 | - | $107.32 M(-15.7%) |
Mar 2013 | - | $127.32 M(-14.5%) |
Dec 2012 | $148.97 M(+74.6%) | $148.97 M(+20.9%) |
Sep 2012 | - | $123.21 M(-11.2%) |
Jun 2012 | - | $138.71 M(+115.2%) |
Mar 2012 | - | $64.45 M(-24.4%) |
Dec 2011 | $85.30 M(+48.1%) | $85.30 M(-4.4%) |
Sep 2011 | - | $89.25 M(-14.1%) |
Jun 2011 | - | $103.87 M(+60.0%) |
Mar 2011 | - | $64.90 M(+12.7%) |
Dec 2010 | $57.58 M(-29.9%) | $57.58 M |
Dec 2009 | $82.16 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual total assets year-on-year change?
- What is Merrimack Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly total assets year-on-year change?
What is Merrimack Pharmaceuticals annual total assets?
The current annual total assets of MACK is $19.19 M
What is the all time high annual total assets for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual total assets is $234.88 M
What is Merrimack Pharmaceuticals annual total assets year-on-year change?
Over the past year, MACK annual total assets has changed by -$648.00 K (-3.27%)
What is Merrimack Pharmaceuticals quarterly total assets?
The current quarterly total assets of MACK is $244.32 M
What is the all time high quarterly total assets for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly total assets is $244.32 M
What is Merrimack Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, MACK quarterly total assets has changed by +$225.02 M (+1165.98%)